Zum Hauptinhalt springen

HIV

07. Mai 2018 | HIV

Impact of HIV knowledge and stigma on the uptake of HIV testing – Results from a community-based participatory research survey among migrants from sub-Saharan Africa in Germany.

Impact of HIV knowledge and stigma on the uptake of HIV testing – Results from a community-based participatory research survey among migrants from sub-Saharan Africa in Germany. Kuehne A, Koschollek C, Santos-Hövener C, Thorlie A, Mü…

06. Mai 2018 | HIV

HIV and Viral Hepatitis Among Imprisoned Key Populations.

HIV and Viral Hepatitis Among Imprisoned Key Populations. Wirtz AL, Yeh PT, Flath NL, Beyrer C, Dolan K. Epidemiol Rev. 2018 Apr 21. doi: 10.1093/epirev/mxy003. Abstract https://www.ncbi.nlm.nih.gov/pubmed/29688317

05. Mai 2018 | HIV

The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity. Zahr NM. Front Aging Neurosci. 2018 Mar 22;10:56. doi: 10.3389/fnagi.2018.00056. eCollection 2018. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874324/

05. Mai 2018 | HIV

HIV treatment as prevention among people who inject drugs - a re-evaluation of the evidence.

HIV treatment as prevention among people who inject drugs - a re-evaluation of the evidence. Fraser H, Mukandavire C, Martin NK, Hickman M, Cohen MS, Miller WC, Vickerman P. Int J Epidemiol. 2017 Apr 1;46(2):466-478. doi: 10.1093/ije/dyw180. http…

03. Mai 2018 | HIV

Highlights of the 25th CROI

Highlights of the 25th CROI Hayward, Peter The Lancet HIV , Volume 5 , Issue 5 , e209 https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30069-9/fulltext

03. Mai 2018 | HIV

Accelerating epidemic control: the role of HIV self-testing

Accelerating epidemic control: the role of HIV self-testing Kojima, Noah et al. The Lancet HIV , Volume 0 , Issue 0 , Published: 24 April 2018, doi.org/10.1016/S2352-3018(18)30063-8 https://www.thelancet.com/journals/lanhiv/article/PIIS2352-…

01. Mai 2018 | HIV

Postexpositions -Prophylaxe: Einsatz antiretroviraler Arzneimittel in der Frühtherapie einer HIV-Infektion

Postexpositions -Prophylaxe: Einsatz antiretroviraler Arzneimittel in der Frühtherapie einer HIV-Infektion Infiziert sich eine Patientin oder ein Patient mit HI-Viren kann dies mit molekularbiologischen Methoden erst etwa zwei Wochen nach der…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten